Seqens Solvents & Phenol Specialties (SPS) has announced that its isopropanol (IPA) plant capacity expansion is nearing completion and is expected to be finalized by the end of Q1 2022. Final engineering tests will be conducted from mid-February to March, with the first IPA batch from the expanded plant to be manufactured by April 1st. The expansion will add a yearly capacity of up to 50 Ktons of Iso propyl Alcohol, increasing the total plant capacity in Roussillon to 120 Kt per year, a 70% increase from current production. The improved plant will also reduce energy consumption by 66% and eliminate a minimum of 10 thousand tons of CO2 emissions. The expanded IPA production will be certified by IPEC, ensuring compliance with GMP rules for pharmaceutical use.
Seqens Solvents & Phenol Specialties (SPS) is proud to confirm that its isopropanol (IPA) plant capacity expansion, originally announced in Q2 2020 and further authorized in November 2020, has been almost completed and due to be finalized as planned by end of Q1 2022.
Final engineering tests will be run from mid of February into March. A first IPA batch from the expanded plant will be manufactured not later than April 1st, fully in line with the expected program.
From that date, Seqens SPS will be able to add a yearly capacity of up to 50 Ktons of Iso propyl Alcohol. The total plant capacity in Roussillon will reach then 120 Kt per year of IPA, scoring a net increase of 70% vs the current production.
Our improved IPA plant will be run under new and enhanced energy standards, reducing the energy consumption by 66% and eliminating a minimum of 10 thousand Tons of CO2 emissions (equivalent to 2175 passenger vehicles driven in one year…or 1,216,426,465 number of smartphones charged…).
The new and expanded IPA production will be also certified by IPEC, achieving and guaranteeing the strict applications of GMP rules to all users of iso propyl Alcohol as a pharmaceutical excipient.